NATALEE Trial Supports Use of Kisqali with HR+/HER2- Early-Stage Breast Cancer at Increased Risk of Recurrence

NATALEE Trial Supports Use of Kisqali with HR+/HER2- Early-Stage Breast Cancer at Increased Risk of Recurrence

NOW
PLAYING
Oncologists Weigh in on Optimal Use of CDK 4/6 Inhibitors as Adjuvant Therapy in Early Breast Cancer
NOW
PLAYING
Neoadjuvant Immunotherapy in Stage III Melanoma: Improved Outcomes with Response-Driven Approach
NOW
PLAYING
Nearly 50% Skip Prescribed Breast Cancer Meds — Physicians Should Focus on Education & Cutting Costs
NOW
PLAYING
For Women With Heavily-Treated Triple-Negative or HR+, HER2- Metastatic Breast Cancer, Padvec Shows Some Anti-Tumor Activity
NOW
PLAYING
Rytelo Gains FDA Approval for Lower-Risk Myelodysplastic Syndrome: Reducing Need For Blood Transfusions & Improving Quality of Life
NOW
PLAYING
Imfinzi Improves Overall & Progression-Free Survival for Patients With Limited-Stage Small Cell Lung Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider